ArticleBMC cancer2023

Interaction analysis of high-risk pathological features on adjuvant chemotherapy survival benefit in stage II colon cancer patients: a multi-center, retrospective study.

Kexuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.